Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics
- 31 December 2000
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 85 (6) , 477-482
- https://doi.org/10.1016/s1081-1206(10)62575-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmaticsAnnals of Allergy, Asthma & Immunology, 2000
- The Role and Contribution of Leukotrienes in AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapyJournal of Allergy and Clinical Immunology, 1996
- Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.Thorax, 1994
- Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.Thorax, 1993
- Oral Challenges to Detect Aspirin and Sulfite Sensitivity in AsthmaAllergy and Asthma Proceedings, 1988
- Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirinJournal of Allergy and Clinical Immunology, 1983
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory periodPublished by Elsevier ,1982
- Aspirin intolerance in asthma *1, *2Detection by oral challengeJournal of Allergy and Clinical Immunology, 1972